Physical and Emotional Burden of Rheumatoid Arthritis in Saudi Arabia: An Exploratory Cross-Sectional Study

por Omair, Mohammed A, Erdogan, Alper, Tietz, Nicole, Alten, Rieke
Publicado 2020

Delayed-release prednisone improves fatigue and health-related quality of life: findings from the CAPRA-2 double-blind randomised study in rheumatoid arthritis

por Alten, Rieke, Grahn, Amy, Holt, Robert J, Rice, Patricia, Buttgereit, Frank
Publicado 2015

Long-term safety, immunogenicity and efficacy comparing FKB327 with the adalimumab reference product in patients with active rheumatoid arthritis: data from randomised double-blind...

por Genovese, Mark C, Kellner, Herbert, Arai, Yasumasa, Muniz, Rafael, Alten, Rieke
Publicado 2020

High Usability and Applicability Ratings for the New SmartClic(®)/ClicWise(®) Injection Device: Evidence from a Health Care Professional Opinion Study

por Alten, Rieke, Moss, Simon, Hahne, Stefanie, Muriset, Angela T., Gruben, David, Latymer, Mark
Publicado 2023

Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes

por Taylor, Peter C., Matucci Cerinic, Marco, Alten, Rieke, Avouac, Jérôme, Westhovens, Rene
Publicado 2022

The Adherence and Outcomes Benefits of Using a Connected, Reusable Auto-Injector for Self-Injecting Biologics: A Narrative Review

por Antalfy, Attila, Berman, Kyle, Everitt, Claire, Alten, Rieke, Latymer, Mark, Godfrey, Charles M.
Publicado 2023

Long-Term Safety of Subcutaneous Abatacept in Rheumatoid Arthritis: Integrated Analysis of Clinical Trial Data Representing More Than Four Years of Treatment

por Alten, Rieke, Kaine, Jeffrey, Keystone, Edward, Nash, Peter, Delaet, Ingrid, Genovese, Mark C
Publicado 2014

Immunogenicity of an adalimumab biosimilar, FKB327, and its reference product in patients with rheumatoid arthritis

por Alten, Rieke, Markland, Colin, Boyce, Malcolm, Kawakami, Kazuki, Muniz, Rafael, Genovese, Mark C.
Publicado 2020

Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007–2017

por Lindner, Lisa, Callhoff, Johanna, Alten, Rieke, Krause, Andreas, Ochs, Wolfgang, Zink, Angela, Albrecht, Katinka
Publicado 2020

A Narrative Literature Review Comparing the Key Features of Musculoskeletal Involvement in Rheumatoid Arthritis and Systemic Lupus Erythematosus

por Dörner, Thomas, Vital, Edward M., Ohrndorf, Sarah, Alten, Rieke, Bello, Natalia, Haladyj, Ewa, Burmester, Gerd
Publicado 2022

Examining patient preferences in the treatment of rheumatoid arthritis using a discrete-choice approach

por Alten, Rieke, Krüger, Klaus, Rellecke, Julian, Schiffner-Rohe, Julia, Behmer, Olaf, Schiffhorst, Guido, Nolting, Hans-Dieter
Publicado 2016

Physical and Emotional Burden of Rheumatoid Arthritis: Data from RA Matters, a Web-Based Survey of Patients and Healthcare Professionals

por Alten, Rieke, van de Laar, Mart, De Leonardis, Francesco, Tietz, Nicole, Guerreiro, Mariana, van Vollenhoven, Ronald
Publicado 2019

Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitin...

por Strand, Vibeke, Kaine, Jeffrey, Alten, Rieke, Wallenstein, Gene, Diehl, Annette, Shi, Harry, Germino, Rebecca, Murray, Christopher W.
Publicado 2020

Randomised study of PF-06410293, an adalimumab (ADL) biosimilar, compared with reference ADL for the treatment of active rheumatoid arthritis: results from weeks 26–52, including a...

por Fleischmann, Roy M, Alvarez, Daniel F, Bock, Amy E, Cronenberger, Carol, Vranic, Ivana, Zhang, Wuyan, Alten, Rieke
Publicado 2021

Long-term efficacy, safety, and immunogenicity of the adalimumab biosimilar, PF-06410293, in patients with rheumatoid arthritis after switching from reference adalimumab (Humira®)...

por Fleischmann, Roy M., Alvarez, Daniel F., Bock, Amy E., Cronenberger, Carol, Vranic, Ivana, Zhang, Wuyan, Alten, Rieke
Publicado 2021

Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept

por Alten, Rieke, Bingham, Clifton O., Cohen, Stanley B., Curtis, Jeffrey R., Kelly, Sheila, Wong, Dennis, Genovese, Mark C.
Publicado 2016

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting

por Alten, Rieke, Burkhardt, Harald, Feist, Eugen, Krüger, Klaus, Rech, Juergen, Rubbert-Roth, Andrea, Voll, Reinhard E., Elbez, Yedid, Rauch, Christiane
Publicado 2018

Relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world study

por Conaghan, P G, Alten, Rieke, Deodhar, Atul, Sullivan, Emma, Blackburn, Stuart, Tian, Haijun, Gandhi, Kunal, Jugl, Steffen M, Strand, Vibeke
Publicado 2020

Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis

por Buttgereit, Frank, Doering, Gisela, Schaeffler, Achim, Witte, Stephan, Sierakowski, Stanislaw, Gromnica-Ihle, Erika, Jeka, Slawomir, Krueger, Klaus, Szechinski, Jacek, Alten, Rieke
Publicado 2010

Long-Term Maintenance of Certolizumab Pegol Safety and Efficacy, in Combination with Methotrexate and as Monotherapy, in Rheumatoid Arthritis Patients

por Fleischmann, Roy, van Vollenhoven, Ronald F., Vencovský, Jiri, Alten, Rieke, Davies, Owen, Mountian, Irina, de Longueville, Marc, Carter, David, Choy, Ernest
Publicado 2017